Succinimide hydroxamic acids as potent inhibitors of histone deacetylase (HDAC)

Bioorg Med Chem Lett. 2002 Oct 21;12(20):2919-23. doi: 10.1016/s0960-894x(02)00622-4.

Abstract

A series of succinimide hydroxamic acids was prepared and evaluated in vitro for HDAC inhibition and tumor cell antiproliferation. While the original macrocyclic analogue 6 was quite potent in both assays, several appropriately substituted non-macrocyclic succinimides, such as 23, were equipotent.

MeSH terms

  • Amino Acids / chemistry
  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / pharmacology*
  • Binding Sites / drug effects
  • Crystallography, X-Ray
  • Enzyme Inhibitors / chemical synthesis*
  • Enzyme Inhibitors / pharmacology*
  • Histone Deacetylase Inhibitors*
  • Histone Deacetylases / chemistry
  • Histone Deacetylases / metabolism
  • Humans
  • Hydroxamic Acids / chemical synthesis*
  • Hydroxamic Acids / metabolism
  • Hydroxamic Acids / pharmacology*
  • Indicators and Reagents
  • K562 Cells
  • Molecular Conformation
  • Structure-Activity Relationship
  • Succinimides / chemical synthesis*
  • Succinimides / metabolism
  • Succinimides / pharmacology*
  • Tumor Cells, Cultured

Substances

  • Amino Acids
  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Histone Deacetylase Inhibitors
  • Hydroxamic Acids
  • Indicators and Reagents
  • Succinimides
  • Histone Deacetylases